CAR-T(CAR-T)细胞疗法在非肿瘤性疾病中的应用
Chimeric antigen receptor T (CAR-T) cell therapy in non-oncological diseases.
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Lymph node-biomimetic scaffold boosts CAR-T therapy against solid tumor.
Lymph node-biomimetic scaffold boosts CAR-T therapy against solid tumor.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
有限的浸润和持久性是嵌合抗原受体 (CAR)-T 细胞在实体瘤中疗效不足的主要原因。在此,我们提出一种三维支架,其灵感来源于淋巴结中 T 细胞增殖的生理过程。该支架集成了负载、递送、激活和扩增 CAR-T 细胞的功能,以增强其对实体瘤的治疗效果。这种多孔装置由聚乳酸-羟基乙酸共聚物通过微流控技术制成,并修饰了 T 细胞刺激信号,包括 anti-CD3、anti-CD28 抗体以及细胞因子。该支架在体外促进 CAR-T 细胞扩增 50 倍,在体内促进细胞扩增 15 倍。特别是,在宫颈肿瘤模型中,它能维持 CAR-T 细胞的持久扩增长达 30 天,并显著抑制肿瘤生长。这种仿生递送策略为 CAR-T 细胞治疗实体瘤提供了一种多功能的细胞递送和激活平台。
The limited infiltration and persistence of chimeric antigen receptor (CAR)-T cells is primarily responsible for their treatment deficits in solid tumors.
Here, we present a three-dimensional scaffold, inspired by the physiological process of T-cell proliferation in lymph nodes. This scaffold gathers the function of loading, delivery, activation and expansion for CAR-T cells to enhance their therapeutic effects on solid tumors. This porous device is made from poly(lactic-co-glycolic acid) by a microfluidic technique with the modification of T-cell stimulatory signals, including anti-CD3, anti-CD28 antibodies, as well as cytokines.
This scaffold fosters a 50-fold CAR-T cell expansion in vitro and a 15-fold cell expansion in vivo . Particularly, it maintains long-lasting expansion of CAR-T cells for up to 30 days in a cervical tumor model and significantly inhibits the tumor growth. This biomimetic delivery strategy provides a versatile platform of cell delivery and activation for CAR-T cells in treating solid tumors.
在 PubMed 查看 → 出版商原文(DOI) 全文 PDF(PMC)· 可下载 治疗专题与资料阅读指南 资料来源与翻译说明 报告译文或资料问题 →
MEMBER ACCOUNT
登录成功会直接打开下一页。